Marker Therapeutics, Inc. - Common Stock (MRKR)
1.8400
-0.0800 (-4.17%)
Marker Therapeutics Inc is a biopharmaceutical company focused on the development of innovative immunotherapy treatments for cancer
The company specializes in creating personalized T cell therapies designed to harness the body's immune system to target and eliminate tumors. By utilizing a unique approach that enhances T cell functionality, Marker Therapeutics aims to provide more effective treatment options for various types of malignancies, contributing to advancements in oncology and improving patient outcomes through precision medicine.
Frequently Asked Questions
Is Marker Therapeutics, Inc. - Common Stock publicly traded?
Yes, Marker Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Marker Therapeutics, Inc. - Common Stock trade on?
Marker Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Marker Therapeutics, Inc. - Common Stock?
The ticker symbol for Marker Therapeutics, Inc. - Common Stock is MRKR on the Nasdaq Stock Market
What is the current price of Marker Therapeutics, Inc. - Common Stock?
The current price of Marker Therapeutics, Inc. - Common Stock is 1.840
When was Marker Therapeutics, Inc. - Common Stock last traded?
The last trade of Marker Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Marker Therapeutics, Inc. - Common Stock?
The market capitalization of Marker Therapeutics, Inc. - Common Stock is 16.42M
How many shares of Marker Therapeutics, Inc. - Common Stock are outstanding?
Marker Therapeutics, Inc. - Common Stock has 8.92M shares outstanding.